Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 137
Back to Home

GHRP-2

A ghrelin-receptor agonist that triggers a growth hormone pulse from the pituitary.

Approved in Japan — but only as a single 100 μg intravenous dose for DIAGNOSING growth hormone deficiency, not as a treatment [6]. The one chronic human study, 8 months in 6 children, raised GH but left IGF-I unchanged [5].

Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards

Growth HormoneApproved diagnostic agent in Japan; no treatment approval anywhere

Suggested dose

100 mcg

Single dose (approved diagnostic use)Onset: Rapid (hours to days)
15-60 minutesHalf-life
HighBioavailability(subcutaneous)
817.97 g/molMolecular weight
Approved diagnostic agent in Japan; no treatment approval anywhereEvidence level

Compound profile

GHRP-2 scientific & efficacy data

Growth Hormone

Peptide profile

GH Release9.5
Recovery Speed9.0
Sleep Quality8.8

Approved diagnostic agent in Japan; no treatment approval anywhere

GHRP-2

100 mcg · Single dose (approved diagnostic use)

Molecular formula

C45H55N9O6

Mol. weight
817.97 g/mol
CAS number
158861-67-7
PubChem
6918245
Developed · 1991
Cyril Y. Bowers
Tulane University

Amino acid sequence

D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2

GH Release

This part is real and well documented. GHRP-2 acts on the growth hormone secretagogue receptor and produces a reproducible GH pulse — reliably enough that Japan approves a single 100 μg intravenous dose as a diagnostic test, with a peak below 15 μg/L taken as evidence of deficiency [6]. The pulse is brief: in 8 months of daily dosing, each injection's effect faded with little carry-over later in the night [5].

Recovery Speed

Not demonstrated, and the usual justification does not hold. Recovery claims run through IGF-1, but in the only chronic human study — 6 children dosed for 8 months — serum IGF-I and IGFBP-3 did not increase at any dose [5]. No trial has measured training recovery, tissue repair or strength with GHRP-2 in healthy adults.

Sleep Quality

No human trial of GHRP-2 has measured sleep. The association comes from growth hormone being released during slow-wave sleep, which is a reason to inject at night rather than evidence of an effect on sleep itself. What has been measured is appetite: food intake rose 33.5% above placebo at the higher infusion rate [7].

Dosing

How much GHRP-2 do I take?

100 mcg · single dose, once — this is a diagnostic test · intravenous

Intravenous

100 mcg

Single dose, once — this is a diagnostic test

Covers all 3 documented dose levels · 2 administration routes · timing · dose-adjustment guidance.

Every documented dose level

PhaseDoseFrequencyRoute
One administration100 mcgSingle dose, once — this is a diagnostic testIntravenous
2 months per dose level, 8 months in total0.3 – 3 mcg/kg/dayOnce dailySubcutaneous
Undefined — no trial has run this schedule100 – 300 mcg per dose1-3 times daily (community practice)Subcutaneous
GHRP-2Single dose, once — this is a diagnostic test

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Suitability

Is GHRP-2 right for me?

Best for growth hormone optimization & muscle building

Best for

Natural Growth Hormone Optimization

GHRP-2 excels at stimulating your pituitary to release more of your own growth hormone. Unlike synthetic HGH, it works with your body's natural feedback systems, creating more physiological GH pulses that mimic what your body did when you were younger.

Recovery and Muscle Building

Athletes and fitness enthusiasts love GHRP-2 for its ability to speed up recovery between workouts. The elevated GH and IGF-1 levels help repair muscle tissue faster, reduce soreness, and support lean muscle growth—especially when combined with proper training and nutrition.

Deep Sleep Enhancement

One of the most noticeable effects users report is dramatically improved sleep quality. GHRP-2 taken before bed can enhance deep sleep phases, which is when your body does most of its repair work. Many users report waking up feeling more refreshed and recovered.

Anti-Aging and Vitality

As we age, natural GH production declines significantly. GHRP-2 helps restore more youthful GH levels, which can translate to better skin elasticity, improved energy, enhanced recovery capacity, and that overall feeling of vitality that tends to fade with age.

Appetite Stimulation

Unlike many peptides that suppress appetite, GHRP-2 is known for increasing hunger. This makes it ideal for hard-gainers trying to build muscle or anyone who struggles to eat enough calories. The appetite boost typically kicks in within 20-30 minutes of injection.

Consider alternatives if

Growth hormone optimization without appetite increaseIpamorelin, GHRP-6 (even stronger appetite), Tesamorelin
Longer-acting GH stimulationCJC-1295 DAC, Sermorelin, Tesamorelin
Direct GH replacementSomatropin (HGH), Norditropin, Genotropin

Do not use if

Pregnant or breastfeeding—safety not established in pregnancyActive cancer or history of cancer—elevated GH/IGF-1 may promote tumor growthPituitary tumor or other pituitary disorders—could worsen underlying conditionUncontrolled diabetes—GHRP-2 can affect blood sugar regulationKnown allergy to GHRP-2 or related peptidesUnder 18 years old unless under medical supervision for growth disorders

Use with caution if

History of carpal tunnel syndrome—GH elevation can worsen symptomsPre-diabetic or insulin resistant—monitor blood sugar closelyTaking corticosteroids—may affect cortisol responseHistory of fluid retention or edemaCardiovascular conditions—consult physician firstUsing other growth hormone secretagogues simultaneously

Not sure?

Compare GHRP-2 with similar peptides to find the best fit for your goals.

Administration

How do I use GHRP-2?

Intravenous (approved diagnostic use) · Subcutaneous injection

Route

Subcutaneous injection into fatty tissue

Best sites

Abdomen (2 inches from navel)—most common and convenientFront of thigh (middle third)Back of upper arm (tricep area)

Covers reconstitution · step-by-step technique · storage · a sample daily schedule.

Safety

Is GHRP-2 safe?

3 common side effects · 2 serious

The largest measured effect in humans is on appetite, and it is not small: in 19 adults, food intake rose 10.2 ± 3.9% at 0.1 mcg/kg/hour (p=0.011) and 33.5 ± 5.8% at 1 mcg/kg/hour (p<0.001) against placebo, with obese participants responding as much as lean ones [7].

The Japanese diagnostic label lists abdominal rumbling, leukocytosis, a feeling of warmth, low blood pressure, nausea, gastric discomfort, abdominal distension, drowsiness and rhinorrhoea as adverse reactions — but that label covers a single 100 μg intravenous dose, not repeated use [6].

In 6 growth-hormone-deficient children given 0.3 to 3.0 mcg/kg/day for 8 months, no side effects or toxicities were observed, in a cohort far too small to detect anything uncommon [5].

One adverse signal from longer infusion: in critically ill men, GHRP-2 given alone at 1 mcg/kg/hour for 5 days raised serum lactate and white cell count by day 5, which the fuller hormonal replacement in the same trial did not [8].

GHRP-2 has one regulatory approval in the world, in Japan, for a single intravenous dose used to diagnose growth hormone deficiency [6]. No regulator has reviewed it as a treatment, so there is no approved safety profile for taking it repeatedly.

The human literature is dominated by acute pituitary-physiology studies — single boluses and short infusions in small groups of volunteers, largely from Bowers and Veldhuis. Chronic dosing evidence is one study in 6 children over 8 months, where IGF-I did not rise [5].

There is no trial in healthy adults taking it for body composition, no long-term safety data, and no cancer-risk data for a compound that raises GH.

Less common

Low blood pressureRaised white cell count and lactate

These typically resolve with continued use or dose adjustment.

Common side effects · experienced by some users

  • Substantially increased food intake

    The largest measured human effect. In 19 adults, ad libitum food intake rose 10.2 ± 3.9% at 0.1 mcg/kg/hour and 33.5 ± 5.8% at 1 mcg/kg/hour against placebo, dose-dependently, and obese participants responded as much as lean ones [7]. Appetite before the meal was higher while fullness afterwards was unchanged — it drives starting to eat, not stopping.

    Management: Treat this as the primary effect to plan around, not a footnote. If the goal is fat loss, a 33% rise in intake works directly against it.

  • Gastrointestinal effects

    Abdominal rumbling, nausea, gastric discomfort and abdominal distension are all listed as adverse reactions on the Japanese diagnostic label, from a single 100 μg intravenous dose [6].

    Management: Reported after a single dose; no management is specified on the label.

  • Feeling of warmth, drowsiness, runny nose

    All three are listed adverse reactions on the Japanese label [6].

    Management: Transient on the label's account.

Stop and seek help if

  • Signs of allergic reaction (rash, swelling, difficulty breathing)
  • Persistent carpal tunnel symptoms (numbness, tingling, weakness in hands)
  • Significant blood sugar elevation or difficulty managing diabetes
  • Pregnancy confirmed or suspected
  • Development of any new medical condition—consult your provider
  • Severe or persistent side effects not improving with dose reduction

Always consult with a healthcare provider before stopping or if you experience any concerning symptoms. This information is for educational purposes and should not replace professional medical advice.

With other peptides

  • Safe:CJC-1295 — Excellent synergy—combining GHRP with GHRH amplifies GH release 5-10x. Can inject together.
  • Caution:Ipamorelin — Both are GHRPs—using together is redundant and may cause excessive appetite stimulation.
  • Caution:GHRP-6 — Both are GHRPs—do not stack together. Choose one based on appetite preference.
  • Safe:Sermorelin — Good synergy as a GHRH analog. Can be combined for enhanced GH release.
  • Safe:BPC-157 — Safe to combine for recovery benefits. Different mechanisms, no interactions.

With medications

  • Caution:Insulin — GH has anti-insulin effects. May need insulin dose adjustment. Monitor closely.
  • Caution:Diabetes medications — May affect blood sugar control. Monitor glucose levels carefully.
  • Caution:Corticosteroids — Both affect cortisol/HPA axis. Use with caution and medical supervision.
  • Safe:Thyroid medications — GH can affect thyroid hormone conversion. Monitor thyroid levels.

With supplements

  • Safe:Arginine — May enhance GH release when taken together. Safe combination.
  • Safe:Glutamine — May support GH release. Safe to combine.
  • Safe:Melatonin — Both taken before bed. May have additive sleep benefits.
  • Safe:Protein supplements — Essential for muscle building goals. Take protein 30+ minutes after peptide injection.

Effectiveness

How do I know GHRP-2 is working?

Approved diagnostic agent in Japan; no treatment approval anywhere · first signs week 1-2

Evidence level

Approved diagnostic agent in Japan; no treatment approval anywhere

Regulatory status

Not FDA approved

Approved in Japan as 注射用GHRP科研100 (pralmorelin hydrochloride, Kaken Pharmaceutical) for the diagnosis of growth hormone deficiency only — a single 100 μg intravenous dose. There is no treatment approval for GHRP-2 in any country.

Onset of effects

Rapid

(hours to days)

How it works

Your pituitary gland naturally releases growth hormone in pulses throughout the day, especially during deep sleep.

GHRP-2 works by mimicking a hormone called ghrelin, which tells your pituitary to release more GH. Think of it like pressing the 'release GH' button more often and more forcefully.

Unlike injecting synthetic GH directly, GHRP-2 works with your body's natural systems—your pituitary still does the work, it just does more of it. This creates more natural, pulsatile GH release patterns similar to what you had when you were younger.

The deeper mechanism

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that acts as a potent GH secretagogue through activation of the growth hormone secretagogue receptor (GHS-R1a), the same receptor targeted by endogenous ghrelin.

Upon binding, GHRP-2 stimulates pituitary somatotrophs to release stored GH in a pulsatile fashion.

Unlike GHRH which acts through the GHRH receptor, GHRP-2 amplifies GH release through a complementary pathway, explaining the synergistic effect when both peptide classes are combined (5-10x amplification).

GHRP-2 also stimulates hypothalamic GHRH release and suppresses somatostatin tone, further enhancing GH output. Additionally, it activates ACTH release from corticotrophs, causing transient cortisol elevation.

The peptide has a plasma half-life of 15-60 minutes, but its effects on GH pulsatility persist longer. Downstream effects include elevated IGF-1 synthesis in the liver and target tissues, mediating many of the anabolic and regenerative benefits attributed to GH.

What to expect

  1. Week 1-2

    What you might notice

    • Increased appetite within 20-30 minutes of each injection
    • Possibly deeper sleep and more vivid dreams
    • Mild water retention or puffiness
    • Getting used to the injection routine

    What's normal

    • Hunger increase is expected and often significant
    • Sleep improvements may be noticeable quickly
    • Some water weight gain is common
    • Flushing or warmth after injection

    What's next

    • Continue consistent dosing schedule
    • Track sleep quality and recovery
    • Note any side effects to discuss dose adjustments
    • Maintain fasted state for each injection
  2. Week 3-4

    What you might notice

    • More consistent sleep improvements
    • Faster recovery between workouts
    • Possible subtle improvements in skin quality
    • Appetite effects may stabilize somewhat

    What's normal

    • Water retention often decreases as body adapts
    • Energy levels may improve
    • Hunger remains elevated but becomes more manageable
    • Full GH benefits take time to manifest

    What's next

    • Consider adding GHRH peptide if seeking maximum results
    • Assess tolerance and adjust dose if needed
    • Continue tracking progress and recovery
    • Ensure nutrition supports your goals
  3. Week 5-8

    What you might notice

    • More noticeable improvements in body composition
    • Enhanced workout performance and recovery
    • Skin may appear more youthful and elastic
    • Consistent sleep quality benefits

    What's normal

    • Changes are gradual—not overnight transformations
    • Results depend heavily on diet and training
    • Some side effects may diminish with adaptation
    • GH benefits compound over time

    What's next

    • Continue at effective dose
    • Consider blood work to check IGF-1, glucose levels
    • Evaluate whether to continue beyond 8 weeks
    • Maintain consistent injection schedule
  4. Week 9-12+

    What you might notice

    • Significant cumulative improvements in recovery and body composition
    • Sustained energy and vitality improvements
    • Continued sleep quality benefits
    • Hair, skin, and nail improvements possible

    What's normal

    • Benefits plateau at optimal levels
    • Body adapts to elevated GH—results maintain rather than accelerate
    • Some users cycle off for 4-8 weeks before resuming

    What's next

    • Evaluate results and decide on continuation
    • Consider cycling off to maintain pituitary sensitivity
    • Get follow-up blood work if continuing long-term
    • Maintain healthy lifestyle habits during any break

Signs it's working

Sleep and Recovery

  • Falling asleep faster and sleeping more deeply
  • Waking up feeling more refreshed and rested
  • More vivid or memorable dreams
  • Reduced muscle soreness after workouts
  • Faster recovery between training sessions

Body Composition

  • Gradual increase in lean muscle mass
  • Reduction in stubborn body fat over time
  • Improved muscle fullness and definition
  • Better workout pumps and vascularity
  • Clothes fitting differently (more muscle, less fat)

General Vitality

  • Improved overall energy levels
  • Better skin elasticity and quality
  • Stronger hair and nails
  • Enhanced sense of well-being
  • Increased appetite (confirms peptide is working)

Not seeing results? Common reasons

  • Expecting an IGF-1 driven effect. In the only chronic human study — 6 growth-hormone-deficient children dosed for 8 months — serum IGF-I and IGFBP-3 did not increase at any dose [5]
  • Expecting a body-composition result that has never been measured. No trial has tested GHRP-2 for muscle, fat, strength or recovery in healthy adults; the percentages that circulate are from rats
  • Eating more without noticing. Food intake rose 33.5% above placebo at 1 mcg/kg/hour in 19 adults, and appetite before meals was higher while fullness afterwards was unchanged [7]
  • A brief pulse rather than a sustained level. GH profiles showed each injection's effect faded with little carry-over later in the night, which is why the authors concluded a longer-acting formulation would be needed for therapy [5]
  • Material of unknown identity or purity. The only regulated product is a Japanese diagnostic vial [6]; everything else is unverified

Key research

2013[1]
“Differential pulsatile secretagogue control of GH secretion in healthy men”Norman C et al.Finding: Testosterone and estradiol positively determine GH responses to GHRP-2 in older men, while BMI negatively affects pulsatile GH secretion during GHRP-2 infusion.View study
2009[2]
“Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women”Veldhuis JD et al.Finding: GHRP-2 was more stimulatory than GHRH for GH release in women. Age and estrogen status together explained 60% of the variability in GHRP-2 effectiveness.View study
2009[3]
“Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism”Veldhuis JD et al.Finding: L-arginine combined with GHRP-2 provides a robust GH stimulus that remains effective even during short-term hormone deficiency, unaffected by visceral fat or IGF-1 levels.View study
2009[4]
“Novel relationships of age, visceral adiposity, IGF-I and IGF binding protein concentrations to GHRH and GHRP efficacies in men”Veldhuis JD et al.Finding: Abdominal visceral fat is a dominant negative predictor of both GHRH and GHRP-2 effectiveness. Fasting IGF-I concentration positively correlates with secretagogue efficacy.View study
1998[5]
“Effects of eight months treatment with graded doses of a GH-releasing peptide (GHRP-2) in GH-deficient children”Mericq V, Cassorla F, Salazar T, Avila A, Iniguez G, Bowers CY, Merriam GRFinding: The only chronic human study of GHRP-2, and it is small. Six prepubertal children with growth hormone deficiency received escalating subcutaneous doses of 0.3, then 1.0, then 3.0 mcg/kg per day, each for a 2-month period, followed by a fourth period combining 3 mcg/kg GHRP-2 with 3 mcg/kg GHRH. Overnight GH secretion rose dose-wise and growth velocity was higher during treatment than before or after. But serum IGF-I and IGFBP-3 DID NOT INCREASE, and the GH profiles showed the effect of each injection was brief with little influence on secretion later in the night. No side effects or toxicities were observed in those 6 children. The authors' own conclusion is that formulations with a longer duration of action would be needed for GHRP-2 to be useful as therapy.View study
2025[6]
“注射用GHRP科研100 (GHRP Kaken 100 for injection, pralmorelin hydrochloride) — Japanese package insert, Kaken Pharmaceutical”Kaken Pharmaceutical Co., Ltd.; Pharmaceuticals and Medical Devices Agency (PMDA), JapanFinding: The only regulatory approval this compound has anywhere, and it is for a diagnostic test rather than a treatment. The approved indication is the diagnosis of growth hormone deficiency (成長ホルモン分泌不全症の診断). The dose is a SINGLE slow intravenous injection given fasted, after dissolving the vial in 10 mL of saline: 100 μg for anyone aged 18 or over, and 2 μg per kg of body weight for ages 4 to under 18, capped at 100 μg for children over 50 kg. Adverse reactions listed on the label are abdominal rumbling, leukocytosis, a feeling of warmth, low blood pressure, nausea, gastric discomfort, abdominal distension, drowsiness and a runny nose. Nothing on this label covers repeated dosing, subcutaneous injection, or use for body composition.View study
2006[7]
“Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake”Laferrère B, Hart AB, Bowers CYFinding: The clearest measurement of what GHRP-2 does to appetite in people. Nineteen healthy weight-stable adults (10 lean, 9 obese) each received, double-blind and in random order, a subcutaneous infusion of GHRP-2 at 1 mcg/kg/hour, 0.1 mcg/kg/hour, or placebo over 270 minutes, then ate freely at a buffet lunch. Food intake rose 10.2 ± 3.9% at the low rate (p=0.011) and 33.5 ± 5.8% at the high rate (p<0.001) against placebo, dose-dependently. Obesity did not blunt the effect — obese participants responded as much as lean ones, in both food intake and GH. Appetite ratings before the meal were higher while fullness afterwards was the same, so the drive is to start eating rather than to stop later.View study
2002[8]
“The combined administration of GHRP-2, TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone”Van den Berghe G, Baxter RC, Weekers F, et al.Finding: Thirty-three critically ill men were randomised to 5 days of placebo (n=7), GHRP-2 alone at 1 mcg/kg/hour (n=9), GHRP-2 plus TRH (n=9), or GHRP-2 plus TRH plus pulsatile GnRH (n=8). GHRP-2 alone reactivated GH secretion and normalised IGF-I, IGFBP-3 and the acid-labile subunit. It did not deliver the metabolic benefit: ureagenesis fell with the two combinations (p=0.01 and p=0.009) but NOT with GHRP-2 alone, and osteocalcin rose only with the triple combination. By day 5, serum lactate and white cell count were increased by GHRP-2 infused alone and with TRH, but not by the triple combination. Restoring one hormonal axis in isolation was not enough, and carried signals the fuller replacement did not.View study

Clinical trials

GHRP-2 tested in people

No registered clinical trial of GHRP-2 was found in the public registries.

That does not mean nobody has studied it — laboratory and animal work is not registered anywhere. It means no study has been declared in advance where regulators and the public can see it, so there are no stated endpoints and no results anyone is obliged to report.

Questions

Frequently asked about GHRP-2

What's the difference between GHRP-2 and Ipamorelin?

Both are GH-releasing peptides, but GHRP-2 is more potent and causes significant appetite increase, while Ipamorelin is gentler with minimal hunger effects. GHRP-2 also stimulates cortisol and prolactin release, whereas Ipamorelin is more selective for GH only. Choose GHRP-2 if you want maximum GH release or need appetite stimulation; choose Ipamorelin for a cleaner, more targeted approach.

Why do I need to take GHRP-2 on an empty stomach?

The Japanese label does specify fasted administration for the diagnostic dose [6], so the instruction itself is sourced. The usual explanation — that food blunts the GH response — has not been tested for GHRP-2 in a published trial, so treat the reason as plausible rather than demonstrated. Note the awkward part: the compound raises food intake by up to a third [7], so fasted dosing and its main pharmacological effect pull in opposite directions.

Can I combine GHRP-2 with other peptides?

Yes, but strategically! GHRP-2 works best when combined with a GHRH peptide like CJC-1295 or Sermorelin—this combination can amplify GH release 5-10 times compared to either alone. However, don't combine GHRP-2 with other GHRPs like Ipamorelin or GHRP-6 as they compete for the same receptor.

How long until I see results from GHRP-2?

It depends entirely on what you are counting as a result, and for most of them the honest answer is that nobody has measured it. The GH pulse is immediate and reliable enough to diagnose on: Japan's approved test samples blood at 15, 30, 45 and 60 minutes after a single 100 mcg intravenous dose [6]. Appetite responds within the same session — food intake at a buffet lunch rose 33.5% above placebo during a 270-minute infusion [7]. Beyond that: in 6 children dosed for 8 months, growth velocity improved but IGF-I never rose [5], and no trial has ever measured muscle, fat, strength, recovery or sleep with GHRP-2 in healthy adults.

Will GHRP-2 make me hungry all the time?

It will make you eat more, and the effect has been measured rather than guessed. In 19 adults given a subcutaneous infusion double-blind against placebo, ad libitum food intake rose 10.2% at 0.1 mcg/kg/hour and 33.5% at 1 mcg/kg/hour — dose-dependent, and just as strong in the obese participants as the lean ones [7]. The pattern is specific: appetite ratings before the meal were higher, while fullness afterwards was the same. So it pushes you to start eating rather than leaving you unsatisfied after. GHRP-2 acts on the same receptor as ghrelin, which is why.

Is GHRP-2 the same as HGH?

No, they work very differently. HGH (somatropin) is the actual growth hormone that you inject directly into your body. GHRP-2 stimulates your own pituitary gland to produce and release more of YOUR natural growth hormone. GHRP-2 creates more physiological, pulsatile GH release patterns, while HGH injections provide constant elevated levels.

What time of day should I take GHRP-2?

The approved label gives one timing instruction: fasted [6]. Beyond that, no human trial of GHRP-2 has compared times of day, so the before-bed and on-waking recommendations are reasoning from the body's own overnight GH pulse rather than a measured result. The chronic study that did dose at night found each injection's effect was brief, with little influence on GH secretion later in the night [5]. The three-times-daily schedule this page used to publish — morning, post-workout, bedtime — appears in no trial and on no label.

How long can I use GHRP-2?

There is no evidence-based answer, and the 8-12 weeks on / 4-8 weeks off pattern that circulates comes from community practice rather than any trial or label. The approved use is a single injection [6]. The longest anyone has been dosed in a published study is 8 months — 6 growth-hormone-deficient children, escalating from 0.3 to 3.0 mcg/kg/day, with no side effects observed in that small group but also no rise in IGF-I [5]. Nobody has studied repeated GHRP-2 in healthy adults at all, so claims about maintaining pituitary sensitivity through cycling are not built on data.

Further reading

GHRP-2 history & related research

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for GHRP-2, on one page.

Medical disclaimer

GHRP-2 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 9, 2026